Virtual ghost
Complex paradigm
- Joined
- Jun 6, 2008
- Messages
- 22,159
Hungary has a take off over the last few days in daily new cases:
24, 73, 91, 132, 158, 292 ... ?
24, 73, 91, 132, 158, 292 ... ?
Not everyone lives in a toilet, some actually live in a city with humans.
Just a couple of weeks ago you were criticizing people in the Coronavirus Blues thread who didn't want COVID-19 positive people from Texas and Arizona coming into their state for medical help. You expressed the need for compassion to take care of our neighbors and working through this together. Now you don't care?People still care about this thing?
Don't be like that. We are in this together. Be proud that your state is helping people it isn't even directly responsible for. Nobody gets sick on purpose, and we have seen this thing spike at different times in different places. Networking care nationally to take care of hot spots should be something we can call get behind.
Another thing this shows is that China is having a second wave of COVID-19. That suggests it is part of this virus' natural progression. The 1918 Pandemic had three waves the second being ten times worst than the first or third waves. I guess we will find out if China's second wave is worse or similar to the first.
What's more, clues gleaned from other coronaviruses, like SARS, suggest T cells' lifespan could be decades long.
Sweden bet on both national character and herd immunity, hoping they would complement each other. Months later, the country has little testing and one of the highest rates of cases.
The US government has said that it will not participate in a global initiative to develop, manufacture and equitably distribute a vaccine for Covid-19 because the effort is co-led by the World Health Organization.
The Covid-19 Vaccines Global Access Facility (Covax) is a plan developed by the WHO, along with the Coalition for Epidemic Preparedness Innovations and Gavi, the Vaccine Alliance, and is meant to accelerate the development and testing of a vaccine and work toward distributing it equally. The WHO announced last month that more than 170 countries were in talks to participate in Covax.
Asked to confirm a report in the Washington Post that the US will not be joining Covax, a White House spokesman, Judd Deere, said in a statement: “Under President Trump’s leadership, vaccine and therapeutic research, development, and trials have advanced at unprecedented speed to deliver groundbreaking, effective medicines driven by data and safety and not held back by government red tape.
A vaccine is almost certain
Then: From the outset of the crisis, there’s been cautious optimism that a vaccine would eventually be developed, but veterans of vaccine creation have been careful to say it often takes years, and there was no guarantee one would ever be developed for Covid-19.
Now: The U.S. government has pledged billions of dollars toward quick development of a vaccine, and several teams around the globe have been working toward the goal for months.
Dozens of vaccine candidates are in various stages of testing by different companies and research groups. Optimism was recently boosted when three separate groups — in China, at Oxford University, and in the United States — announced successful early trials, each generating an immune response to the novel coronavirus and appearing to be safe. These candidate vaccines must go through larger human trials involving people beyond the healthy 18-to-55-year-olds typical of trials so far. And then they would need to be produced in great quantities — hundreds of millions of doses for the United States alone, and billions globally. Scaling up production, after any federal approval, is expected to take months.
What it means: “Absolutely, for sure,†a successful vaccine will be developed for Covid-19, says Barry Bloom, PhD, an immunologist and infectious disease expert at Harvard T.H. Chan School of Public Health. “And we will get more than one.†With each company able to ramp up production of its own vaccine separately, that would mean more total doses would be available sooner. How effective any of the vaccines will be remains to be seen — a vaccine needs to be just 50% effective to make it to market, Bloom says. The other big question is when, says Andrea Amalfitano, DO, dean of the College of Osteopathic Medicine at Michigan State University.
Expecting a vaccine being administered to the public by March 2021 “is not out of the realm of possibility,†Amalfitano says in a phone interview, but he adds that there is still no guarantee of a vaccine that soon.